Stock selection in the information technology and financials sectors contributed to the relative performance of the fund.

Three Motley Fool contributors think they've found unstoppable dividend stocks to buy right now. Here's why they picked ...

Daily stock price moves often dominate headlines, but shifts in fundamental ranking scores can reveal a deeper story. This ...

Alphabet, Exxon Mobil, and AbbVie remain Zacks' top coverage picks as each navigates industry shifts while driving long-term ...

NORTH CHICAGO, IL, USA I August 21, 2025 I AbbVie (NYSE: ABBV) today announced positive topline results from the second of two pivotal studies of the Phase 3 ...

Alphabet drives cloud and AI momentum, Exxon Mobil boosts energy projects, and AbbVie rides strong drug launches despite ...

For the second time in the last three weeks, AbbVie has revealed successful results from a phase 3 study of Rinvoq as a treatment for the hair-loss disease alopecia areata (AA). | For the second time ...

AbbVie on Thursday said the Phase 3 study evaluating the safety and efficacy of Rinvoq in patients with severe forms of the disease that causes sudden hair loss met its primary endpoint of 80% or more ...

Recently, the Second Circuit, Sixth Circuit, and a Texas district again rejected the pharmaceutical industry’s challenges to ...

AbbVie Inc. has turned heads recently with a notable uptick in stock searches. Over the last month, its shares soared by +9.2 ...

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Analysts are intrested in these 5 stocks: ( ($ABBV) ), ( ($DOW) ), ( ($KTOS) ), ( ($RKT) ) and ( ($AMAT) ). Here is a breakdown of their recent ...